Translate
About
Ibrands Corporation (OTCCE:IBRC) — investor relations, events, news, and company updates on 6ix.
Latest News
Jun 29 2020
iBrands Corporation Reports Reduction of Brain Inflammation/Depression Associated Biochemical Pathway Using QuadraMune™ in Animal Studies
Jun 22 2020
iBrands Corporation Reports QuadraMune Reduces Myeloid Suppressor Cells in 4T1 Mouse Model of Breast Cancer
Jun 17 2020
iBrands Corporation Announces Clinical Trial For Immune Booster Product
Apr 27 2020
iBrands Corporation Adds Immune Booster To Nutraceutical Product Line
Mar 23 2020
iBrands Corporation Enters Into Distribution Agreement With Medical Supply Group
Financials
Revenue
$126.41 K
Market Cap
$4.42 M
EPS
-0.21